- 1、本文档共28页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Targeting the endocannabinoid system: to enhance or reduce?;Introduction
Ups and downs of endocannabinoids in disease
Therapeutic use of indirect agonists
Therapeutic use of inverse agonists/antagonists;;;Recptors;;Development strategy of endocannabinoid system targeted drug;Introduction
Ups and downs of endocannabinoids in disease
Therapeutic use of indirect agonists
Therapeutic use of inverse agonists/antagonists;NOTE;Eatting disorders;Neural-disease;;Roles of endocannabinoids duringcentral neuroinflammation;Roles of endocannabinoids duringperipheral neuroinflammation;Liver disease and osteoporosis;Other diseases;Introduction
Ups and downs of endocannabinoids in disease
Therapeutic use of indirect agonists
Therapeutic use of inverse agonists/antagonists;Inhibitors of catabolism;Endocannabinoid indirect agonists: inhibitors of FAAH and MAGL;Inhibitors of cellular reuptake;Endocannabinoid indirect agonists: Inhibitors of cellular reuptake;Potential disadvantages;Introduction
Ups and downs of endocannabinoids in disease
Therapeutic use of indirect agonists
Therapeutic use of inverse agonists/antagonists;;CB1 receptor antagonists/inverse agonists in clinical trials (not all);CB2 receptor antagonists/inverse agonists in preclinical trials (not all);Potential disadvantages;Perhaps no other signalling system discovered during the past 15 years is raising as many expectations for the development of new therapeutic drugs, encompassing such a variety of pathological conditions, targeting so many different organs and tissues, and using such a wide range of potential strategies for treatment, as the endocannabinoid system.
文档评论(0)